5-HT3 receptor over-expression decreases ethanol self administration in transgenic mice

被引:36
作者
Engel, SR
Lyons, CR
Allan, AM [1 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Med, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA
关键词
5-HT3; receptor; over-expression; transgenic animal model; alcohol drinking;
D O I
10.1007/s002130050763
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tho 5-HT3 receptor is thought to play a role in the reward pathway and the phenomena of drug abuse by modulating dopamine release in the mesolimbic pathway. Studies involving this receptor have been hampered due to the low level of 5-HT3 receptors in the CNS. A 5-HT3 receptor over-expressing mouse was produced to study the role of this receptor in the rewarding properties of drugs of abuse. Over-expression was restricted to the forebrain by controlling gene expression with the Ca2+ calmodulin (CAM) kinase II alpha promoter. No over-expression was detected in other body organs nor the cerebellum, as measured by ligand binding and Northern analysis. 5-HT3 receptor over-expressing mice drank less alcohol than non-transgenic mice in a two-bottle free choice test. Over-expression of the 5-HT3 receptor in these mice resulted in a decrease in ethanol consumption. These mice should prove useful in testing hypothesis regarding a common reward pathway for drugs of abuse and the role 5-HT3 receptors play in this pathway.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 47 条
[1]   CHARACTERIZATION OF [H-3] YM060, A POTENT AND SELECTIVE 5-HT3 RECEPTOR RADIOLIGAND, IN THE CEREBRAL-CORTEX OF RATS [J].
AKUZAWA, S ;
MIYATA, K ;
FUKUTOMI, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :37-42
[2]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551
[3]   VOLUNTARY CONSUMPTION OF ETHANOL IN 15 INBRED MOUSE STRAINS [J].
BELKNAP, JK ;
CRABBE, JC ;
YOUNG, ER .
PSYCHOPHARMACOLOGY, 1993, 112 (04) :503-510
[4]   COMMON PHARMACOLOGICAL AND PHYSICOCHEMICAL PROPERTIES OF 5-HT3 BINDING-SITES IN THE RAT CEREBRAL-CORTEX AND NG 108-15 CLONAL CELLS [J].
BOLANOS, FJ ;
SCHECHTER, LE ;
MIQUEL, MC ;
EMERIT, MB ;
RUMIGNY, JF ;
HAMON, M ;
GOZLAN, H .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1541-1550
[5]  
BURGIN KE, 1990, J NEUROSCI, V10, P1788
[6]   SEROTONIN-3 RECEPTOR AND ETHANOL-STIMULATED DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS [J].
CAMPBELL, AD ;
MCBRIDE, WJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (04) :835-842
[7]   DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE [J].
CARBONI, E ;
ACQUAS, E ;
FRAU, R ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) :515-519
[8]   REDUCTION IN CORTICAL 5-HT3 BINDING-SITES FOLLOWING A UNILATERAL 6-HYDROXYDOPAMINE LESION OF THE MEDIAL FOREBRAIN-BUNDLE IN RATS [J].
CICINSAIN, L ;
JENNER, P .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 (01) :105-110
[9]   Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies [J].
Crawley, JN ;
Belknap, JK ;
Collins, A ;
Crabbe, JC ;
Frankel, W ;
Henderson, N ;
Hitzemann, RJ ;
Maxson, SC ;
Miner, LL ;
Silva, AJ ;
Wehner, JM ;
WynshawBoris, A ;
Paylor, R .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :107-124
[10]  
DRY W, 1995, ALCOHOL, V12, P387